drugset / Trial / NCT01161004

Recovery Effect of Sugammadex Measured by Bispectral and Neurosense Indices

NCT01161004

Phase 4 Completed 50 enrolled Hopital Foch
RandomizedCrossoverTriple-blindTreatment

Summary

It has been demonstrated that antagonism of neuromuscular blockade (neostigmine 0.04 mg kg-1) affects depth of anaesthesia with an increase in bispectral index (mean maximal change of 7.1) and middle-latency auditory evoked potentials (mean maximal change of 9.7). Sugammadex has a quicker and more complete effect than neostigmine. This study aims to demonstrate if sugammadex administration increases bispectral and neurosense indices of the depth of anesthesia while patients still receive propofol-remifentanil iv anesthesia.

Timeline

Start
2010-09
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 2 mg/kg
Subject Sugammadex Other / unclassified 4 mg/kg

Indications

No indication recorded.